Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer

Por Shitara, Kohei, Kim, Tae Min, Yokota, Tomoya, Goto, Masahiro, Satoh, Taroh, Ahn, Jin-Hee, Kim, Hyo Song, Assadourian, Sylvie, Gomez, Corinne, Harnois, Marzia, Hamauchi, Satoshi, Kudo, Toshihiro, Doi, Toshihido, Bang, Yung-Jue
Publicado no Oncotarget (2017)